White Paper
The Increasing Impact of Real World Evidence Platforms, and Their Future Potential
Jul 30, 2020

The real world data (RWD) and real world evidence (RWE) landscape continues to evolve rapidly and pharmaceutical companies are increasingly moving from multiple one-off secondary data studies towards a standing, multipurpose evidence infrastructure. As adoption expands, evidence platforms will be integral to ongoing product success, providing continuous, high-quality, real-time data and insights to all critical stakeholders: physicians, payers and regulators. A single source of evidence truth will become the basis for multi-stakeholder engagement and collaboration, improving the quality and efficiency of healthcare delivery.

In this paper, discover more about:

  • Evidence platform fundamentals, including established, emerging, and future use cases
  • Key challenges that are being addressed through evidence platforms
  • Examples of evidence platforms in use today
  • The future of evidence platforms and drivers of success
Contact Us